LIF and Cachexia: Taken together, these results demonstrate that LIF overexpression in mice inhibits hepatic de novo lipogenesis, which may contribute to the decreased levels of small LC-TGs in the serum and liver tissues in TgLC mice with TAM injection and C26 tumor-bearing mice that develop cachexia.